#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Albright's disease Prader-Willi syndrome Toxic epidermal necrolysis Pleural mesothelioma Ependymoma Neonatal asphyxia Hypocalcaemia Chordoma Leukocyte adhesion deficiency Chronic myeloid leukaemia (in remission) Deafness bilateral Malignant neoplasm of choroid Penile squamous cell carcinoma Cardiac arrest Factor VIII deficiency More trials…

    Learn about Rare Diseases

    Encephalitis autoimmune – Diagnostics Mucopolysaccharidosis Hepatic angiosarcoma – Basic Information Congenital nephrogenic diabetes insipidus – Trials in Disease Pemphigus – Life with Disease Leiomyosarcoma metastatic – Trials in Disease Gaucher’s disease type III – Treatment Rett syndrome – Treatment Pyogenic sterile arthritis pyoderma gangrenosum and acne syndrome – Life with Disease Propionic acidaemia – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Hydrochlorothiazide Gd2Il18Cart Telisotuzumab Vedotin Tovinontrine Urapidil Lisocabtagene Maraleucel ZOLPIDEM TARTRATE Human Von Willebrand Factor Divarasib Ict01 Kyv-101 Pioglitazone Petrelintide SOFTISAN 378 Placebo AMO959 Mosunetuzumab NVG-2089 Dnth103 AUR200 More therapies…

    Learn about Your Condition

    Peritoneal dialysis Malignant peritoneal neoplasm Indolent systemic mastocytosis Premature baby Cholangiosarcoma Cervical dysplasia Epicondylitis Pleomorphic leiomyosarcoma Post cardiac arrest syndrome Sexual dysfunction Skin neoplasm excision Stomatitis Intracranial calcification Intellectual disability Acoustic neuroma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study on Betamethasone Sodium Phosphate to Prevent Asthma in Children with First-time Rhinovirus-induced Wheezing

    Recruiting

    3 1 1
    Investigated Diseases:
    • Bronchiolitis
    • Wheezing
    Investigated Drugs:
    • Betamethasone Sodium Phosphate
    Finland Norway Sweden

  • Study on Adjusted Ciprofloxacin Dosing for Patients with Kidney Impairment and Bacterial Infections

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Bacterial infection
    Investigated Drugs:
    • Ciprofloxacin
    • Ciprofloxacin Hydrochloride
    The Netherlands

  • Study on the Safety of Tumor Treating Fields with Oxaliplatin, Calcium Folinate, Irinotecan Hydrochloride, and Fluorouracil for Metastatic Pancreatic Cancer Patients

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Pancreatic carcinoma metastatic
    Investigated Drugs:
    • Calcium Folinate
    • Fluorouracil
    • Irinotecan Hydrochloride
    Spain

  • Study on Low-Dose Colchicine for Patients with Peripheral Artery Disease to Reduce Cardiovascular Risks

    Recruiting

    3 1 1
    Investigated Diseases:
    • Intermittent claudication
    • Peripheral arterial occlusive disease
    Investigated Drugs:
    • Colchicine
    Belgium Germany Italy The Netherlands

  • Study on the Safety and Effectiveness of NVD-003 Implant for Adults with Difficult-to-Heal Lower Leg Bone Fractures

    Recruiting

    2 1 1
    Investigated Drugs:
    • Autologous Adipose-Derived Stem Cells
    Belgium Luxembourg

  • Study on High-Dose Rifampicin Safety for Adults with Complex Tuberculosis Using Isoniazid, Pyrazinamide, and Ethambutol Combination

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Tuberculosis
    Investigated Drugs:
    • Ethambutol Hydrochloride
    • Isoniazid
    • Pyrazinamide
    The Netherlands Spain
Previous Page
1 … 265 266 267 268 269 … 1,648
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!